Pierre‐Yves Le Roux

Does ¹⁸F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?

Ronan Abgral, S. Querellou, G. Potard et al. · Journal of Nuclear Medicine · 2008 · 241 citations · Full text

EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond

Marika Bajc, C. Schümichen, Thomas Grüning et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 210 citations · Full text

Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial

Philippe Robin, Pierre‐Yves Le Roux, Benjamin Planquette et al. · The Lancet Oncology · 2015 · 105 citations

Thrombosis, Pulmonary Embolism, Venous Disease +13

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

Elske Quak, Pierre‐Yves Le Roux, Michael S. Hofman et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 99 citations · Full text

Prognostic value of interim FDG PET/CT in Hodgkin’s lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria

Pierre‐Yves Le Roux, Thomas Gastinne, Steven Le Gouill et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 89 citations

Lymphoid Neoplasia, Prognostic Evaluation, International Harmonization Project +8